GGrantIndex
Sort

11,323 grants matching glioblastoma

GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS

$280,434
University Of California San Francisco · R01 · FY2001 · CA

Development of Novel Inducers of Non-Apoptotic Cell Death to Target Glioblastoma

$280,329
William A Maltese · University Of Toledo Health Sci Campus · R01 · FY2014 · CA

High-Content Imaging & Analysis Core

$280,327
Gustavo Kunde Rohde · University Of Virginia · U54 · FY2023 · CA

Molecular Oncogenic Properties of Mutant p53

$280,136
Xinbin Chen · University Of California At Davis · R01 · FY2011 · CA

Development of Mouse Neurofibromatosis Model for Preclinical Testing

$280,100
Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Molecular Imaging of Phospho-FADD and its role in resistance to therapy

$279,926
Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · R01 · FY2011 · CA

Novel approaches to enhance tumor cell cytotoxicity of alkylating agents

$279,830
Robert W Sobol · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA

Eastern Cooperative Oncology Group

$279,595
Arlene A Forastiere · Johns Hopkins University · U10 · FY2008 · CA

Eastern Cooperative Oncology Group

$279,594
Arlene A Forastiere · Johns Hopkins University · U10 · FY2007 · CA

Therapy of glioblastoma with novel apoptotic peptide

$279,579
Northern California Institute Res &Educ · R01 · FY2004 · CA

Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth

$279,535
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA

Correlative trial of fenretinide against Glioblastomas

$279,463
University Of Texas Md Anderson Can Ctr · R21 · FY2003 · CA

Activated EGF Receptor in Ovarian Cancer

$279,365
Laurie G Hudson · University Of New Mexico · R01 · FY2006 · CA

Vascular Maintenance and Brain Tumor Refractory

$279,350
Vanderbilt University · R01 · FY2005 · NS

Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination

$279,180
W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA

MDM2 AND CELL GROWTH AND TUMORIGENESIS

$279,140
Univ Of Massachusetts Med Sch Worcester · R01 · FY2002 · CA

Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination

$279,127
W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA

Identification of small molecule inhibitors of USP15

$278,962
Natalia Martinez · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Novel DNA damage response inhibitor and alkylator combinations for GBM

$278,878
Ranjit Bindra · Mayo Clinic Rochester · U19 · FY2023 · CA

Non-canonical signal pathway for Crk in breast cancer

$278,781
Raymond B Birge · Rbhs-New Jersey Medical School · R01 · FY2013 · CA

Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma

$278,494
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2022 · CA

Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination

$278,463
W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA

TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS

$278,443
Massachusetts General Hospital · R01 · FY2000 · CA

INBRE RESEARCH CORE

$278,392
Ulhas P Naik · University Of Delaware · P20 · FY2009 · RR

Neural Stem Cell Based Virotherapy for Malignant Glioma

$278,358
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2023 · CA